Basics Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals Inc is engaged in developing and commercializing differentiated therapies to patients living with chronic skin conditions. It develops solutions in to treat skin conditions, such as acne, atopic dermatitis, and scarring. IPO Date: February 1, 2007 Sector: Healthcare Industry: Pharma Market Cap: $6.05M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.62% Avg Daily Range (30 D): $0.10 | 3.19% Avg Daily Range (90 D): $0.12 | 3.98% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .69M Trade Size Avg Trade Size (Sh.): 231 Avg Trade Size (Sh.) (30 D): 227 Avg Trade Size (Sh.) (90 D): 117 Institutional Trades Total Inst.Trades: 15 Avg Inst. Trade: $.97M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Jul 12, 2024 @ 9:35 AM Why Ericsson Shares Are Trading Higher; Here Are 2... Source: Avi Kapoor Jun 28, 2024 @ 12:50 PM Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Mom... Source: Zacks Equity Research Jan 24, 2024 @ 1:14 PM Why Netflix Shares Are Trading Higher By 10%; Here... Source: Avi Kapoor Dec 18, 2023 @ 6:05 PM Why Lantheus Holdings Shares Are Trading Lower By ... Source: Avi Kapoor Dec 18, 2023 @ 1:10 PM Why Arcutis Biotherapeutics Shares Are Trading Hig... Source: Avi Kapoor Financials   TTM Q4 2025 FY 2025 Basic EPS $-2.79 $-.39 $-2.79 Diluted EPS $-2.79 $-.39 $-2.79 Revenue $ 14.29M $ 3.75M $ 14.29M Gross Profit $ 5.47M $ 1.53M $ 5.47M Net Income / Loss $ -2.91M $ -.23M $ -2.91M Operating Income / Loss $ -3.71M $ -.66M $ -3.71M Cost of Revenue $ 8.82M $ 2.23M $ 8.82M Net Cash Flow $ 2.25M $ .14M $ 2.25M PE Ratio     Splits Aug 30, 2024:   1:20 Jun 20, 2019:   1:9 Jun 27, 2016:   1:5 Apr 01, 2013:   1:7